Health experts slam US mass purchase of licensed Covid-19 drug remdesivir
The Department of Health and Human Services said it had secured 500,000 treatments of the drug through September, representing 100% of Gilead’s July production capacity and 90% of its capacity in August and September.
No hay comentarios:
Publicar un comentario